-
ECB opens door to September rate-hike as Iran war flares up
-
Oil soars to $100 on fresh Mideast attacks
-
World Bank estimates Venezuela quakes caused $19.6 bn in damage
-
Coal-fired power generation rising globally on Mideast war: IEA
-
Italy's far-right line up to defend jeweller who killed robbers
-
Premier League champions Arsenal sign Greece winger Tzolis from Brugge
-
AI-led boom in IPOs raises concerns about a bust
-
French Jewish DJ sues after activists disrupt gig: lawyer
-
Klopp expected to be named new Germany coach on Friday
-
Venice film festival promises Pattinson, Oasis and Musk doc
-
ECB holds rates as Iran war flare-up threatens to drive prices higher
-
ASEAN calls for open straits as US-Iran war casts shadow
-
MEXC's "Kickoff Fest" Trading Event Concludes with Top Individual Reward of 27,352 USDT
-
Ford and Geely to form joint venture at struggling Spain plant
-
Oil soars close to $100 on fresh Mideast attacks
-
Russia warns US against Ukraine arms sales in Manila meeting
-
India's angry Gen Z protesters say Modi must fix accountability
-
New UK PM announces tax cut for struggling pubs
-
Barca sign Adeyemi from Borussia Dortmund
-
Supporters flood India's 'cockroach' protesters with food
-
EasyJet profits nosedive on Mideast war
-
Modi vows punishment for exam leaks fuelling India protests
-
EU fines Google 890 mn euros, risking US fury
-
Norway set to make formal complaint to FIFA over Balogun red card saga
-
France evacuates thousands of tourists as fire rages in pine forest
-
Floods in northeast India kill at least 41
-
French Jewish DJ sues after activists disrupt stage show: lawyer
-
Nestle siphons off bottled water business into joint venture
-
Nokia says AI, cloud boosted sales in second quarter
-
Hundreds hospitalised in Japan heatwave 'disaster'
-
Repsol says profit more than triples on higher oil prices
-
Renault says sales stalled in first half
-
TotalEnergies says profit doubled on Mideast war
-
EasyJet says profits nosedive on Mideast war
-
Giant swing on Swiss peak aims to boost summer tourism as Alps warm
-
Modi vows punishment for exam fraud fuelling India protests
-
ASEAN to call for open straits as US-Iran war casts shadow
-
Six candidates in race to lead UN set for televised debate
-
AI catches up with humans to score 100% at top maths contest
-
Comic-Con kicks off with Marvel's return
-
South Korea election office raided in fake turnout figures probe: investigators
-
Dutch riders dreaming of crazy party corner of Alpe d'Huez
-
Killer whales: orcas blow fish to bits 'for fun', study finds
-
Houthis target Red Sea shipping as US hits Iran
-
Deadly wildfires force thousands from homes in parts of Europe
-
Record-equalling Red Sox streak halted at 15 wins
-
Tech bounce lifts Asia stocks, oil extends gains on US-Iran fears
-
Messi-less Miami beat Fire 3-2 to spoil Lewandowski's MLS debut
-
Surrounded by militias, Sudanese fear endless cycle of war
-
Mercedes expect Hungary challenge from Hamilton and Ferrari
'Love hormone'? Not so fast, new study suggests
The "love hormone" oxytocin has long been thought key to behaviours including pairing up with a partner and nurturing offspring, but a new study in prairie voles is raising doubts.
The research found that voles bred to lack functioning receptors for oxytocin were still able to form strong pairs, produce young and nurse -- all behaviours previously believed to depend on the hormone.
Prairie voles are one of the few mammals that mate for life, and are often used to study social behaviours like pair-forming in animals.
In past studies, voles given drugs that stopped oxytocin being processed no longer formed pairs, and mothers failed to produce milk for their young.
Psychiatrist Devanand Manoli and neurobiologist Nirao Shah produced genetically altered prairie voles without working oxytocin receptors, and then observed how the mutant male and female voles behaved.
To their shock, the mutant voles appeared to have no difficulty pairing up with non-genetically altered partners, and mutant females could still deliver and nurse young, unlike those in the drug-driven studies.
"We were certainly surprised," said Manoli, an assistant professor at the University of California, San Francisco.
The results suggest that oxytocin is not the main, or only, driver of activities like partnering or nursing, he said.
"What the genetics reveals is that there isn't a 'single point of failure' for behaviours that are so critical to the survival of the species," he told AFP.
- 'Very complex behaviours' -
That didn't mean there were no differences, however.
Some male mutant voles that paired with ordinary female partners didn't show the aggression towards interloping females that would normally be expected.
And while mutant females produced and nursed litters, some had fewer pups per litter than their counterparts, and fewer of their offspring survived to weaning, the paper published Friday in the journal Neuron explains.
Pups born to mutant mothers also tended to weigh less, suggesting that they were not able to nurse as effectively.
The study only involved pairing of mutant voles with "wild-type" partners, and the researchers said pairings with two mutant partners could produce different results.
Still, as a whole, the findings suggest a different picture of oxytocin's role in several important behaviours.
That could be because animals bred without the receptors developed "other compensatory pathways" that helped them pair up and nurse, said Shah, a professor at Stanford University.
But the researchers suggest it likely means oxytocin is only part of a set of genetic factors that control social behaviour.
"What I think our studies reveal is that there are multiple pathways that regulate these very complex behaviours," said Manoli.
Oxytocin has sometimes been suggested as a way to treat attachment disorders and other neuropsychiatric issues, but there is little settled science on how effective it is.
Now the researchers hope to investigate what other hormones and receptors may be involved in behaviours like pairing and nursing.
"These other pathways might serve as new therapeutic targets," Manoli said.
E.Schubert--BTB